British Journal of Oral and Maxillofacial Surgery
Volume 47, Issue 8 , Pages 587-593 , December 2009

Prognostic factors in malignant tumours of the salivary glands

  • Paul M. Speight

      Affiliations

    • Department of Oral & Maxillofacial Pathology, School of Clinical Dentistry, University of Sheffield, Claremont Crescent, Sheffield S10 2TA, United Kingdom
    • Corresponding Author InformationCorresponding author at: Department of Oral and Maxilofacial Pathology, School of Clinical Dentistry, University of Sheffield, Claremont Crescent, Sheffield S10 2TA, United Kingdom. Tel.: +44 0114 271 7951; fax: +44 0114 271 7894.
    • ,
  • A. William Barrett

      Affiliations

    • Department of Histopathology, Queen Victoria Hospital, Holtye Road, East Grinstead, West Sussex RH19 3DZ, United Kingdom

,Accepted 27 March 2009.

References 

  1. Speight PM, Barrett AW. Salivary gland tumours. Oral Dis. 2002;8:229–240
  2. Ellis GL, Auclair PL. Classification of salivary gland neoplasms. In:  Ellis GL,  Auclair PL,  Gnepp DR editor. Surgical pathology of the salivary glands. Philadelphia: Saunders; 1991;p. 129–134
  3. Ostman J, Anneroth G, Gustafsson H, Tavelin B. Malignant salivary gland tumours in Sweden 1960–1989—an epidemiological study. Oral Oncol. 1997;33:169–176
  4. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999;120:834–840
  5. Sun EC, Curtis R, Melbye M, Goeder JJ. Salivary gland cancer in the United States. Cancer Epidemiol Biomarkers Prev. 1999;8:1095–1100
  6. Koivunen P, Suutala L, Schorsch I, Jokinenk K, Alho OP. Malignant epithelial salivary gland tumors in northern Finland: incidence and clinical characteristics. Eur Arch Otorhinolaryngol. 2002;259:146–149
  7. In:  Barnes L,  Eveson JW,  Reichart P,  Sidransky D editor. World Health Organization classification of tumors: pathology and genetics of head and neck tumors. Lyon IARC Press; 2005;
  8. Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol. 2008;44:407–417
  9. Ellis GL, Auclair PL. Salivary gland neoplasms: general considerations. In:  Ellis GL,  Auclair PL,  Gnepp DR editor. Surgical pathology of the salivary glands. Philadelphia: Saunders; 1991;p. 135–164
  10. Ellis GL, Auclair PL. Atlas of tumor pathology. Tumors of the salivary glands. Series 3, Fascicle 17. Washington, DC: Armed Forces Institute of Pathology; 1996;
  11. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg. 1986;8:177–184
  12. Spiro RH, Thaler HT, Hicks WF, Kher UA, Huvos AH, Strong EW. The importance of clinical staging of minor salivary gland carcinoma. Am J Surg. 1991;162:330–336
  13. Cheuk W, Chan JKC. Salivary gland tumours. In:  Fletcher CDM editors. Diagnostic histopathology of tumors. 3rd ed.. London: Churchill Livingstone; 2007;p. 239–325
  14. Spiro RH. Factors affecting survival in salivary gland cancers. In:  McGurk M,  Renehan A editor. Controversies in the management of salivary gland disease. Oxford: Oxford University Press; 2001;p. 143–150
  15. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg. 1990;116:290–293
  16. Renehan AG, Gleave EN, Slevin NJ, McGurk M. Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer. 1999;80:1296–1300
  17. Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Keus RB, Hart AA. Stage as major long term outcome predictor in minor salivary gland carcinoma. Cancer. 2000;89:1195–1204
  18. Slevin N, Frankenthaler R. The role of radiotherapy in the management of salivary gland cancer. In:  McGurk M,  Renehan A editor. Controversies in the management of salivary gland disease. Oxford: Oxford University Press; 2001;p. 163–172
  19. Spiro RH, Huvos AG. Stage means more than grade in adenoid cystic carcinoma. Am J Surg. 1992;164:623–628
  20. Plambeck K, Friedrich RE, Schmelzle R. Mucoepidermoid carcinoma of salivary gland origin: classification, clinical–pathological correlation, treatment results and long-term follow-up in 55 patients. J Craniomaxillofac Surg. 1996;24:133–139
  21. McGurk M. Management of salivary gland cancer: clinically or pathologically based? Overview. In:  McGurk M,  Renehan A editor. Controversies in the management of salivary gland disease. Oxford: Oxford University Press; 2001;p. 155–161
  22. Frankenthaler RA, Luna MA, Lee SS, et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg. 1991;117:1251–1256
  23. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998;82:1217–1224
  24. Vander Poorten VL, Balm AJ, Hilgers FJ, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85:2057–2067
  25. Vander Poorten VL, Balm AJ, Hilgers FJ, et al. Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors. Cancer. 1999;85:2255–2264
  26. Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63:917–928
  27. Vander Poorten VL, Hart AA, van der Laan BF, et al. Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985–1994 Dutch Head and Neck Oncology Cooperative Group database. Cancer. 2003;97:1453–1463
  28. Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25:835–845
  29. Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. J Oral Pathol Med. 2008;37:309–318
  30. Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer. 1999;86:207–219
  31. Evans HL, Luna MA. Polymorphous low grade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas. Am J Surg Pathol. 2000;24:1319–1328
  32. Batsakis JG, Luna MA, el-Naggar A. Histopathologic grading of salivary gland neoplasms. III. Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol. 1990;99:1007–1009
  33. Tomich CE. Adenoid cystic carcinoma. In:  Ellis GL,  Auclair PL,  Gnepp DR editor. Surgical pathology of the salivary glands. Philadelphia: Saunders; 1991;p. 333–349
  34. Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer. 1978;42:265–282
  35. Nascimento AG, Amaral AL, Prado LA, Kligerman J, Silveira TR. Adenoid cystic carcinoma of salivary glands: a study of 61 cases with clinicopathologic correlation. Cancer. 1986;57:312–319
  36. Spiro RH. The controversial adenoid cystic carcinoma. Is this cancer curable and where does it fail?. In:  McGurk M,  Renehan A editor. Controversies in the management of salivary gland disease. Oxford: Oxford University Press; 2001;p. 207–211
  37. Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 1997;174:495–498
  38. Matsuba HM, Spector GJ, Thawley SE, Simpson JR, Mauney M, Pikul FJ. Adenoid cystic salivary gland carcinoma. A histopathologic review of treatment failure patterns. Cancer. 1986;57:519–524
  39. da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, de Almeida OP, Kowalski LP. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol. 2006;42:139–146
  40. Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys. 1995;32:619–626
  41. Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Adenoid cystic carcinoma of the head and neck—a 20 years experience. Int J Oral Maxillofac Surg. 2004;33:25–31
  42. Chen AM, Bucci MK, Weinberg V, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006;66:152–159
  43. Jones AS, Hamilton JW, Rowley H, Husband D, Helliwell TR. Adenoid cystic carcinoma of the head and neck. Clin Otolaryngol. 1997;22:434–443
  44. Huang M, Ma DQ, Sun K, Yu G, Guo C, Gao F. Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg. 1997;26:435–439
  45. Soo KC, Carter RL, O’Brien CJ, Barr L, Bliss JM, Shaw HJ. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope. 1986;96:1145–1148
  46. Barrett AW, Speight PM. The controversial adenoid cystic carcinoma. The implications of histological grade and perineural invasion. In:  McGurk M,  Renehan A editor. Controversies in the management of salivary gland disease. Oxford: Oxford University Press; 2001;p. 211–217
  47. Luna MA, el-Naggar A, Batsakis JG, Weber RS, Garnsey LA, Goepfert H. Flow cytometric DNA content of adenoid cystic carcinoma of submandibular gland. Arch Otolaryngol Head Neck Surg. 1990;116:1291–1296
  48. Eibling DE, Johnson JT, McCoy JP, et al. Flow cytometric evaluation of adenoid cystic carcinoma: correlation with histologic subtype and survival. Am J Surg. 1991;162:367–372
  49. Beckhardt RN, Weber RS, Zane R, et al. Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope. 1995;105:1155–1160
  50. Pohar S, Gay H, Rosenbaum P, et al. Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys. 2005;61:112–118
  51. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26:154–162
  52. Frankenthaler RA, Byers RM, Luna MA, Callender DL, Wolf P, Goepfert H. Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol Head Neck Surg. 1993;119:517–520
  53. Eneroth CM. Facial nerve paralysis. A criterion of malignancy in parotid tumors. Arch Otolaryngol. 1972;95:300–304

PII: S0266-4356(09)00103-X

doi: 10.1016/j.bjoms.2009.03.017

British Journal of Oral and Maxillofacial Surgery
Volume 47, Issue 8 , Pages 587-593 , December 2009

Article Tools

* Image Usage & Resolution